Role of Non-coding RNAs in Rheumatoid Arthritis and Supervision Mechanism of Chinese Medicine

Overview

Journal Chin J Integr Med

Date 2025 Jan 8

PMID 39776040

Authors

Shu Li

Hao-Xiang Fang

Lei Wan

Jian Liu

Affiliations

Soon will be listed here.

Abstract

The prevalence of rheumatoid arthritis (RA) has sharply increased in recent years, posing a serious threat to human health. RA is characterized as a chronic, multisystem disease with morning stiffness and symmetric small joint pain. However, its fundamental processes are poorly understood. With the advancements in molecular biology techniques, a growing body of research indicates that numerous non-coding RNAs (ncRNAs) are essential for the pathogenesis of RA. These ncRNAs not only contribute to the onset of RA but also play a role in the pathological processes of RA development, including synovial immune inflammation and bone destruction. Chinese medicine (single compounds, single herbs, and compound formulae, as well as non-drug therapies such as acupuncture and moxibustion), offer significant benefits for treating RA. This study examined the role of 3 different ncRNA types (circular RNA, long ncRNA, and microRNA) as biomarkers in RA diagnosis, as well as their regulatory roles in rheumatoid arthritis fibroblast-like synoviocytes functions such as inflammatory response, proliferation, cell cycle, apoptosis, and invasion. Additionally, the study explored the mechanisms by which Chinese medicine regulates these ncRNAs, with the goal of offering innovative strategies for RA treatment.

References

Cush J . Rheumatoid Arthritis: Early Diagnosis and Treatment. Rheum Dis Clin North Am. 2022; 48(2):537-547. DOI: 10.1016/j.rdc.2022.02.010. View

Finckh A, Gilbert B, Hodkinson B, Bae S, Thomas R, Deane K . Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18(10):591-602. DOI: 10.1038/s41584-022-00827-y. View

Paganelli R, Petrarca C, Di Gioacchino M . Biological clocks: their relevance to immune-allergic diseases. Clin Mol Allergy. 2018; 16:1. PMC: 5763605. DOI: 10.1186/s12948-018-0080-0. View

Rantapaa Dahlqvist S, Andrade F . Individuals at risk of seropositive rheumatoid arthritis: the evolving story. J Intern Med. 2019; 286(6):627-643. PMC: 6878216. DOI: 10.1111/joim.12980. View

Tsaltskan V, Firestein G . Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022; 67:102304. PMC: 9942784. DOI: 10.1016/j.coph.2022.102304. View

Zhang Z, Wang Y, Xu Q, Zhou X, Ling Y, Zhang J . Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. Pharmaceuticals (Basel). 2023; 16(10). PMC: 10610387. DOI: 10.3390/ph16101440. View

Tsiapalis D, Floudas A, Tertel T, Boerger V, Giebel B, Veale D . Therapeutic Effects of Mesenchymal/Stromal Stem Cells and Their Derived Extracellular Vesicles in Rheumatoid Arthritis. Stem Cells Transl Med. 2023; 12(12):849-862. PMC: 10726408. DOI: 10.1093/stcltm/szad065. View

Li Z, Chen M, Wang Z, Fan Q, Lin Z, Tao X . Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone Joint Res. 2023; 12(2):91-102. PMC: 9950669. DOI: 10.1302/2046-3758.122.BJR-2022-0269.R1. View

Jose A, Rasool M . Myricetin ameliorates the IL-21-induced tumorigenic phenotype of adjuvant-induced arthritis FLS by modulating the choline kinase signaling cascade. In Vitro Cell Dev Biol Anim. 2023; 59(10):811-820. DOI: 10.1007/s11626-023-00827-6. View

10.

Ji L, Li T, Chen H, Yang Y, Lu E, Liu J . The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 2023; 13(1):230. PMC: 10734085. DOI: 10.1186/s13578-023-01188-z. View

11.

Lodde V, Murgia G, Simula E, Steri M, Floris M, Idda M . Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases. Biomolecules. 2020; 10(7). PMC: 7407480. DOI: 10.3390/biom10071044. View

12.

Chen Q, Geng Q, Yu X, Lu F, Li J, Liu H . High-throughput RNA-sequencing reveals novel targets of tofacitinib in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2023; 41(11):2167-2176. DOI: 10.55563/clinexprheumatol/g2v2ae. View

13.

Qu S, Yang X, Li X, Wang J, Gao Y, Shang R . Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015; 365(2):141-8. DOI: 10.1016/j.canlet.2015.06.003. View

14.

Li H, Wang L, Wang Y, Li X, Pan H . Differences in the expression of long noncoding RNAs in peripheral blood mononuclear cells indicate potential biomarkers for rheumatoid arthritis. Int Immunopharmacol. 2024; 134:112218. DOI: 10.1016/j.intimp.2024.112218. View

15.

Liu R, Jiang C, Li J, Li X, Zhao L, Yun H . Serum-derived exosomes containing NEAT1 promote the occurrence of rheumatoid arthritis through regulation of miR-144-3p/ROCK2 axis. Ther Adv Chronic Dis. 2021; 12:2040622321991705. PMC: 8082996. DOI: 10.1177/2040622321991705. View

16.

Ma L, Liu H, Shao P, Lv Q . Upregulated miR-146b-3p predicted rheumatoid arthritis development and regulated TNF-α-induced excessive proliferation, motility, and inflammation in MH7A cells. BMC Immunol. 2024; 25(1):36. PMC: 11188492. DOI: 10.1186/s12865-024-00629-9. View

17.

Lu H, Yang Y, Kuang D, Liu P, Yang J . Expression profile of circRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis. BMC Med Genomics. 2022; 15(1):77. PMC: 8981773. DOI: 10.1186/s12920-022-01225-9. View

18.

Zhi L, Liang J, Huang W, Ma J, Qing Z, Wang X . Circ_AFF2 facilitates proliferation and inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-375/TAB2 axis. Exp Mol Pathol. 2021; 119:104617. DOI: 10.1016/j.yexmp.2021.104617. View

19.

Wen J, Liu J, Wang X, Wang J . Expression and clinical significance of circular RNAs related to immunity and inflammation in patients with rheumatoid arthritis. Int Immunopharmacol. 2021; 92:107366. DOI: 10.1016/j.intimp.2021.107366. View

20.

Ouyang Q, Liu C, Lu X, Liang R, Zhao J, Yang M . Identification of Circular RNAs Circ_0005008 and Circ_0005198 in Plasma as Novel Biomarkers for New-Onset Rheumatoid Arthritis. Front Pharmacol. 2021; 12:722017. PMC: 8440797. DOI: 10.3389/fphar.2021.722017. View